BioNTech Expands Cancer Research Through CureVac Acquisition
Kilder
- Genengnews: Early Steps in Amyloid-Beta Plaque Formation Tracked in Alzheimer’s Disease - Genetic Engineering and Biotechnology News
- Nature: Targeting DNA damage in ageing: towards supercharging DNA repair - Nature
- Nature: An instantaneous voice-synthesis neuroprosthesis - Nature
- Statnews: BioNTech to buy CureVac in $1.25 billion deal, saying it will bolster cancer work - statnews.com
- Statnews: FDA clears Capsida gene therapy for clinical trials - statnews.com
- Fiercebiotech: BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal - Fierce Biotech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.